Supplementary Figure 3 from Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase–Deficient Renal Cell Carcinoma

Supplementary Figure 3. Forest plot showing the prognostic value of clinicopathologic and molecular features in patients treated with first-line ICI+TKI combination therapy. HR<1 indicates better survival in the comparator group, while HR>1 indicates better survival in the control group. TMB, tumor mutation burden; MUT, mutation; WT, wild type; TPS, tumor proportion score; CCP, cell cycle progression; Sig., signature.